Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications

Chinese Science Bulletin

Volumn 57, Issue 31, 2012, Pages 3961-3971

  Martinez, Jonathan O ^a,b   Brown, Brandon S ^a,b   Quattrocchi, Nicoletta ^a   Evangelopoulos, Michael ^a   Ferrari, Mauro ^a   Tasciotti, Ennio ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

cancer; drug delivery; multifunctional; multistage; nanomedicine; nanoparticle; porous silicon; third generation nanocarriers

Indexed keywords

EID: 84868206810     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-012-5387-5     Document Type: Review

References (89)

1. Sanvicens N, Marco M P. Multifunctional nanoparticles-properties and prospects for their use in human medicine. Trends Biotechnol, 2008, 26: 425-433.
2. Babincova M, Altanerova V, Altaner C, et al. In vivo heating of magnetic nanoparticles in alternating magnetic field. Med Phys, 2004, 31: 2219-2221.
3. Pastan I, Hassan R, Fitzgerald D J, et al. Immunotoxin therapy of cancer. Nat Rev Cancer, 2006, 6: 559-565.
4. O'Brien M E, Wigler N, Inbar M, et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin hcl (caelyx/doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. Ann Oncol, 2004, 15: 440-449.
5. Melancon M P, Lu W, Yang Z, et al. In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol Cancer Ther, 2008, 7: 1730-1739.
6. Ghaghada K B, Ravoori M, Sabapathy D, et al. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One, 2009, 4: e7628.
7. Tang F, Li L, Chen D. Mesoporous silica nanoparticles: Synthesis, biocompatibility and drug delivery. Adv Mater, 2012, 24: 1504-1534.
8. Qian K K, Bogner R H. Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. J Pharm Sci, 2012, 101: 444-463.
9. Chiappini C, Tasciotti E, Fakhoury J, et al. Tailored porous silicon microparticles: Fabrication and properties. Chem Phys Chem, 2010, doi: 10. 1002/cphc. 200900914.
10. Longmire M, Choyke P L, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: Considerations and caveats. Nanomedicine (Lond), 2008, 3: 703-717.
11. Musacchio T, Torchilin V P. Recent developments in lipid-based pharmaceutical nanocarriers. Front Biosci: A J Virtual Libr, 2011, 16: 1388-1412.
12. van Vlerken L E, Amiji M M. Multi-functional polymeric nano-particles for tumour-targeted drug delivery. Expert Opin Drug Deliv, 2006, 3: 205-216.
13. Wu S H, Hung Y, Mou C Y. Mesoporous silica nanoparticles as nanocarriers. Chem Commun (Camb), 2011, 47: 9972-9985.
14. Du Y Z, Cai L L, Li J, et al. Receptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles. Int J Nanomed, 2011, 6: 1559-1568.
15. Shin H C, Alani A W, Cho H, et al. A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs. Mol Pharm, 2011, 8: 1257-1265.
16. Thierry B, Al-Ejeh F, Brown M P, et al. Immunotargeting of functional nanoparticles for MRI detection of apoptotic tumor cells. Adv Mater, 2009, 21: 541-545.
17. Jing Y, Zhu Y, Yang X, et al. Ultrasound-triggered smart drug release from multifunctional core-shell capsules one-step fabricated by coaxial electrospray method. Langmuir, 2011, 27: 1175-1180.
18. Muhammad F, Guo M, Qi W, et al. Ph-triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dis-solution of zno nanolids. J Am Chem Soc, 2011, 133: 8778-8781.
19. Letfullin R R, Iversen C B, George T F. Modeling nanophotothermal therapy: Kinetics of thermal ablation of healthy and cancerous cell organelles and gold nanoparticles. Nanomedicine, 2011, 7: 137-145.
20. Stern J M, Stanfield J, Kabbani W, et al. Selective prostate cancer thermal ablation with laser activated gold nanoshells. J Urol, 2008, 179: 748-753.
21. Hedlund A, Ahren M, Gustafsson H, et al. Gd(2)o(3) nanoparticles in hematopoietic cells for MRI contrast enhancement. Int J Nanomed, 2011, 6: 3233-3240.
22. Toth E, Bolskar R D, Borel A, et al. Water-soluble gadofullerenes: Toward high-relaxivity, pH-responsive MRI contrast agents. J Am Chem Soc, 2005, 127: 799-805.
23. Hasenpusch G, Geiger J, Wagner K, et al. Magnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lung. Pharm Res, 2012, doi: http://dx. doi. org/10. 1007/s11095-012-0682-z.
24. Yigit M V, Moore A, Medarova Z. Magnetic nanoparticles for cancer diagnosis and therapy. Pharm Res, 2012, doi: http://dx. doi. org/10. 10. 1007/s11095-012-0679-7.
25. Wang X, Li J, Wang Y, et al. Hft-t, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. ACS Nano, 2009, 3: 3165-3174.
26. Moghimi S M, Hunter A C, Murray J C. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev, 2001, 53: 283-318.
27. Howard M D, Jay M, Dziubla T D, et al. Pegylation of nanocarrier drug delivery systems: State of the art. J Biomed Nanotechnol, 2008, 4: 133-148.
28. Linkov I, Satterstrom F K, Corey L M. Nanotoxicology and nanomedicine: Making hard decisions. Nanomedicine, 2008, 4: 167-171.
29. Nel A, Xia T, Madler L, et al. Toxic potential of materials at the nanolevel. Science, 2006, 311: 622-627.
30. Suh W H, Suslick K S, Stucky G D, et al. Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol, 2009, 87: 133-170.
31. Godin B, Tasciotti E, Liu X, et al. Multistage nanovectors: From concept to novel imaging contrast agents and therapeutics. ACC Chem Res, 2011, 44: 979-989.
32. Sakamoto J H, van de Ven A L, Godin B, et al. Enabling individualized therapy through nanotechnology. Pharmacol Res, 2010, 62: 57-89.
33. Godin B, Serda R E, Sakamoto J, et al. Nanoparticles for cancer detection and therapy. Nanotechnology. New York: Wiley-VCH Verlag GmbH & Co. KGaA, 2010.
34. Riehemann K, Schneider S W, Luger T A, et al. Nanomedicine-challenge and perspectives. Angew Chem Int Edi, 2009, 48: 872-897.
35. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol, 2001, 19: 316-317.
36. Huang X, Jain P K, El-Sayed I H, et al. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci, 2008, 23: 217-228.
37. West J L, Halas N J. Engineered nanomaterials for biophotonics applications: Improving sensing, imaging, and therapeutics. Annu Rev Biomed Eng, 2003, 5: 285-292.
38. Hirsch L R, Gobin A M, Lowery A R, et al. Metal nanoshells. Ann Biomed Eng, 2006, 34: 15-22.
39. Hirsch L R, Stafford R J, Bankson J A, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA, 2003, 100: 13549-13554.
40. O'Neal D P, Hirsch L R, Halas N J, et al. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett, 2004, 209: 171-176.
41. Gobin A M, Lee M H, Halas N J, et al. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett, 2007, 7: 1929-1934.
42. Loo C, Lin A, Hirsch L, et al. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat, 2004, 3: 33-40.
43. Loo C, Lowery A, Halas N, et al. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett, 2005, 5: 709-711.
44. Tam F, Goodrich G P, Johnson B R, et al. Plasmonic enhancement of molecular fluorescence. Nano Lett, 2007, 7: 496-501.
45. Bardhan R, Grady N K, Halas N J. Nanoscale control of near-infrared fluorescence enhancement using Au nanoshells. Small, 2008, 4: 1716-1722.
46. Bardhan R, Grady N K, Cole J R, et al. Fluorescence enhancement by Au nanostructures: Nanoshells and nanorods. ACS Nano, 2009, 3: 744-752.
47. Bardhan R, Chen W X, Perez-Torres C, et al. Nanoshells with targeted simultaneous enhancement of magnetic and optical imaging and photothermal therapeutic response. Adv Funct Mater, 2009, 19: 3901-3909.
48. Schwartzberg A M, Olson T Y, Talley C E, et al. Synthesis, characterization, and tunable optical properties of hollow gold nanospheres. J Phys Chem B, 2006, 110: 19935-19944.
49. Lu W, Xiong C, Zhang G, et al. Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin Cancer Res, 2009, 15: 876-886.
50. You J, Shao R, Wei X, et al. Near-infrared light triggers release of paclitaxel from biodegradable microspheres: Photothermal effect and enhanced antitumor activity. Small, 2010, 6: 1022-1031.
51. You J, Zhang G, Li C. Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. ACS Nano, 2010, 4: 1033-1041.
52. Souza G R, Christianson D R, Staquicini F I, et al. Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents. Proc Natl Acad Sci USA, 2006, 103: 1215-1220.
53. Souza G R, Staquicini F I, Christianson D R, et al. Combinatorial targeting and nanotechnology applications. Biomed Microdevices, 2010, 12: 597-606.
54. Sengupta S, Eavarone D, Capila I, et al. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature, 2005, 436: 568-572.
55. Ashley C E, Carnes E C, Phillips G K, et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater, 2011, 10: 389-397.
56. Irvine D J. Drug delivery: One nanoparticle, one kill. Nat Mater, 2011, 10: 342-343.
57. Doshi N, Zahr A S, Bhaskar S, et al. Red blood cell-mimicking synthetic biomaterial particles. Proc Natl Acad Sci USA, 2009, 106: 21495-21499.
58. Merkel T J, Jones S W, Herlihy K P, et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc Natl Acad Sci USA, 2011, 108: 586-591.
59. Hu C M, Zhang L, Aryal S, et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA, 2011, 108: 10980-10985.
60. Wong C, Stylianopoulos T, Cui J, et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci USA, 2011, 108: 2426-2431.
61. von Maltzahn G, Park J H, Lin K Y, et al. Nanoparticles that communicate in vivo to amplify tumour targeting. Nat Mater, 2011, 10: 545-552.
62. Tasciotti E, Liu X, Bhavane R, et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol, 2008, 3: 151-157.
63. Sakamoto J, Annapragada A, Decuzzi P, et al. Antibiological barrier nanovector technology for cancer applications. Expert Opin Drug Deliv, 2007, 4: 359-369.
64. Bayliss S C, Heald R, Fletcher D I, et al. The culture of mammalian cells on nanostructured silicon. Adv Mater, 1999, 11: 318-321.
65. Chin V, Collins B E, Sailor M J, et al. Compatibility of primary hepatocytes with oxidized nanoporous silicon. Adv Mater, 2001, 13: 1877-1880.
66. Canham L. Bioactive silicon structure fabrication through nanoetching techniques. Adv Mater, 1995, 7: 1033-1037.
67. Canham L, Reeves C L, Newey J, et al. Derivatized mesoporous silicon with dramatically improved stability in simulated human blood plasma. Adv Mater, 1999, 11: 1505-1507.
68. Decuzzi P, Lee S, Decuzzi M, et al. Adhesion of microfabricated particles on vascular endothelium: A parametric analysis. Ann Biomed Eng, 2004, 32: 793-802.
69. Decuzzi P, Ferrari M. The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials, 2006, 27: 5307-5314.
70. Gentile F, Curcio A, Indolfi C, et al. The margination propensity of spherical particles for vascular targeting in the microcirculation. J Nanobiotechnol, 2008, 6: 9.
71. Gentile F, Chiappini C, Fine D, et al. The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows. J Biomech, 2008, 41: 2312-2318.
72. Gentile F, Ferrari M, Decuzzi P. The transport of nanoparticles in blood vessels: The effect of vessel permeability and blood rheology. Ann Biomed Eng, 2008, 36: 254-261.
73. Lee S Y, Ferrari M, Decuzzi P. Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology, 2009, 20: 495101.
74. Lee S Y, Ferrari M, Decuzzi P. Design of bio-mimetic particles with enhanced vascular interaction. J Biomech, 2009, 42: 1885-1890.
75. Ananta J S, Godin B, Sethi R, et al. Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances t1 contrast. Nat Nanotechnol, 2010, 5: 815-821.
76. Tanaka T, Mangala L S, Vivas-Mejia P E, et al. Sustained sirna delivery by mesoporous silicon particles for cancer treatment. Cancer Res, 2010, 70: 3687-3696.
77. Serda R E, Mack A, Pulikkathara M, et al. Cellular association and assembly of a multistage delivery system. Small, 2010, 6: 1329-1340.
78. Serda R E, Mack A, van de Ven A L, et al. Logic-embedded vectors for intracellular partitioning, endosomal escape, and exocytosis of nanoparticles. Small, 2010, 6: 2691-2700.
79. Serda R E, Ferrati S, Godin B, et al. Mitotic trafficking of silicon microparticles. Nanoscale, 2009, 1: 250-259.
80. Shen H, You J, Zhang G, et al. Cooperative, nanoparticle-enabled thermal therapy of breast cancer. Adv Healthc Mater, 2012, 1: 84-89.
81. Tanaka T, Mangala L S, Vivas-Mejia P E, et al. Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res, 2010, 70: 3687-3696.
82. Godin B, Gu J, Serda R E, et al. Tailoring the degradation kinetics of mesoporous silicon structures through pegylation. J Biomed Mater Res A, 2010, 94: 1236-1243.
83. Tasciotti E, Godin B, Martinez J O, et al. Near-infrared imaging method for the in vivo assessment of the biodistribution of nanoporous silicon particles. Mol Imaging, 2011, 10: 56-68.
84. Tanaka T, Godin B, Bhavane R, et al. In vivo evaluation of safety of nanoporous silicon carriers following single and multiple dose intravenous administrations in mice. Int J Pharm, 2010, 402: 190-197.
85. Decuzzi P, Godin B, Tanaka T, et al. Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release, 2010, 141: 320-327.
86. van de Ven A L, Kim P, Haley O, et al. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. J Control Release, 2011, doi: http://dx. doi. org/10. 1016/j. jconrel. 2011. 10. 021.
87. Mann A P, Tanaka T, Somasunderam A, et al. E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrow. Adv Mater, 2011, 23: H278-H282.
88. De Rosa E, Chiappini C, Fan D, et al. Agarose surface coating influences intracellular accumulation and enhances payload stability of a nano-delivery system. Pharm Res, 2011, 28: 1520-1530.
89. Fan D, De Rosa E, Murphy M B, et al. Mesoporous silicon-PLGA composite microspheres for the double controlled release of biomolecules for orthopedic tissue engineering. Adv Funct Mater, 2012, 22: 282-293.